KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Asset Utilization Ratio: 2011-2025

Historic Asset Utilization Ratio for Rigel Pharmaceuticals (RIGL) over the last 10 years, with Sep 2025 value amounting to 1.26.

  • Rigel Pharmaceuticals' Asset Utilization Ratio rose 6.78% to 1.26 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.26, marking a year-over-year increase of 6.78%. This contributed to the annual value of 1.28 for FY2024, which is 37.19% up from last year.
  • According to the latest figures from Q3 2025, Rigel Pharmaceuticals' Asset Utilization Ratio is 1.26, which was down 10.32% from 1.40 recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Asset Utilization Ratio ranged from a high of 1.40 in Q2 2025 and a low of 0.54 during Q1 2022.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 1.14 (2023), whereas its average is 1.13.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first crashed by 34.55% in 2022, then surged by 87.13% in 2023.
  • Rigel Pharmaceuticals' Asset Utilization Ratio (Quarterly) stood at 0.84 in 2021, then increased by 14.09% to 0.96 in 2022, then grew by 4.45% to 1.01 in 2023, then rose by 17.57% to 1.18 in 2024, then increased by 6.78% to 1.26 in 2025.
  • Its Asset Utilization Ratio stands at 1.26 for Q3 2025, versus 1.40 for Q2 2025 and 1.19 for Q1 2025.